China vs Western Pacific (WHO region): Cases started on MDR-TB treatment
China
13,984
in 2024
Western Pacific (WHO region)
34,878
in 2024
China rank
3rd
Western Pacific (WHO region) rank
6th
Cases started on MDR-TB treatment over time
- China
- Western Pacific (WHO region)
How they compare
Western Pacific (WHO region) currently reports 34,878 against 13,984 in China, a difference of 20,894.
That makes Western Pacific (WHO region)'s figure about 2.5 times China's.
Across all 16 years both countries report, Western Pacific (WHO region) has been ahead every year.
China ranks 3rd and Western Pacific (WHO region) ranks 6th of 193 countries.
Western Pacific (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 458 | 1,449 | 991 | Western Pacific (WHO region) |
| 2010s | 4,884 | 13,760 | 8,875 | Western Pacific (WHO region) |
| 2020s | 12,695 | 32,164 | 19,469 | Western Pacific (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, China or Western Pacific (WHO region)?
- Western Pacific (WHO region), at 34,878 against 13,984 in China as of 2024.
- What is the difference in cases started on mdr-tb treatment between China and Western Pacific (WHO region)?
- 20,894, with Western Pacific (WHO region) ahead.
- How many years of comparable data are there for China and Western Pacific (WHO region)?
- 16 years are reported by both, from 2009 to 2024.
- How do China and Western Pacific (WHO region) rank globally for cases started on mdr-tb treatment?
- China ranks 3rd and Western Pacific (WHO region) ranks 6th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.